<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1636607</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2025.1636607</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Correction: Polygoni Multiflori Radix Praeparata polysaccharides enhance gut health and mitigate ischemic stroke by regulating SCFA and amino acid metabolism in gut microbiota</article-title>
<alt-title alt-title-type="left-running-head">Ruan et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2025.1636607">10.3389/fphar.2025.1636607</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Ruan</surname>
<given-names>Lingyu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3048657/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Zhennan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Mengyun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Qi</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qing</surname>
<given-names>Qing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1633016/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Hongyan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tao</surname>
<given-names>Yuheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Liqun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Junsong</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/424177/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ge</surname>
<given-names>Wenhao</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2980584/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Pharmacy and School of Biological and Food Engineering</institution>, <institution>Changzhou University</institution>, <addr-line>Changzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>School of Pharmacy</institution>, <institution>Modern Industrial College of Traditional Chinese Medicine and Health</institution>, <institution>Lishui University</institution>, <addr-line>Lishui</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Center of Molecular Metabolism</institution>, <institution>Nanjing University of Science and Technology</institution>, <addr-line>Nanjing</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>The Second People&#x2019;s Hospital of Changzhou</institution>, <institution>The Third Affiliated Hospital of Nanjing Medical University</institution>, <addr-line>Changzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Changzhou Medical Center</institution>, <institution>Nanjing Medical University</institution>, <addr-line>Changzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/15167/overview">Michael Heinrich</ext-link>, University College London, United Kingdom</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Junsong Wang, <email>wang.junsong@gmail.com</email>; Wenhao Ge, <email>wenhaoge3323@njmu.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>06</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1636607</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>06</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Ruan, Wang, Zheng, Zheng, Qing, Lin, Tao, Wang, Wang and Ge.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Ruan, Wang, Zheng, Zheng, Qing, Lin, Tao, Wang, Wang and Ge</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Pharmacol." journal-id-type="nlm-ta" xlink:href="10.3389/fphar.2025.1580055" ext-link-type="doi">A Correction on <article-title>Polygoni Multiflori Radix Praeparata polysaccharides enhance gut health and mitigate ischemic stroke by regulating SCFA and amino acid metabolism in gut microbiota</article-title> by Ruan L, Wang Z, Zheng M, Zheng Q, Qing Q, Lin H, Tao Y, Wang L, Wang J and Ge W (2025). Front. Pharmacol. 16:1580055. doi: <object-id>10.3389/fphar.2025.1580055</object-id>
</related-article>
<kwd-group>
<kwd>polygoni multiflori radix praeparata</kwd>
<kwd>polysaccharides</kwd>
<kwd>acute ischemic stroke</kwd>
<kwd>gut microbiota</kwd>
<kwd>metabolomics</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ethnopharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>There was an error in <xref ref-type="fig" rid="F3">Figure 3</xref> as published. The authors inadvertently substituted a 40&#xd7; image from the Sham group with a 40&#xd7; image from the HCK group in <xref ref-type="fig" rid="F3">Figure 3A</xref>. Because intestinal histology differs markedly between groups (fold architecture, mucosal arrangement, etc.), the mismatch was readily apparent. The incorrect original 40&#xd7; image of the Sham group was an enlarged image of the HCK 20&#xd7; image. The authors have now retrieved the correct 40&#xd7; micrographs for both the Sham and HCK groups from the raw data and have reconstructed <xref ref-type="fig" rid="F3">Figure 3A</xref> accordingly. The corrected <xref ref-type="fig" rid="F3">Figure 3</xref> appears below.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>PMP has an ameliorating effect on colon injury in MCAO rats. <bold>(A)</bold> Representative micrographs of H&#x26;E staining in the colon. <bold>(B)</bold> Representative immunohistochemical images and statistical maps of tight junction protein. n &#x3d; 4. &#x2a;p &#x3c; 0.05, &#x2a;&#x2a;p &#x3c; 0.01 and &#x2a;&#x2a;&#x2a;p &#x3c; 0.001, MCAO group vs. Sham group; &#x23;p &#x3c; 0.05, &#x23;&#x23;p &#x3c; 0.01 and &#x23;&#x23;&#x23;p &#x3c; 0.001, dosing group vs. MCAO group.</p>
</caption>
<graphic xlink:href="fphar-16-1636607-g003.tif">
<alt-text content-type="machine-generated">Histological analysis showing intestinal tissue samples across different conditions: Sham, MCAO, LM, HM, and HCK. Panel A illustrates hematoxylin and eosin staining at two magnifications (twenty times and forty times). Panel B shows immunohistochemical staining for ZO-1, Occludin, and Claudin 1. Bar graphs depict the positive rate percentages for each protein, indicating changes in expression across conditions.</alt-text>
</graphic>
</fig>
<p>There was an error in <xref ref-type="fig" rid="F4">Figure 4</xref> as published. Previously, in <xref ref-type="fig" rid="F4">Figure 4B</xref> the scale bar was positioned outside the image. This has now been adjusted to ensure a consistent style. The corrected <xref ref-type="fig" rid="F4">Figure 4</xref> appears below.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>PMP ameliorates MCAO-induced inflammatory response in rats&#x0027; colon. Representative immunohistochemical images and statistical maps of inflammatory factors. n &#x003D; 4. &#x002A;p &#x003c; 0.05, &#x002A;&#x002A;p &#x003c; 0.01 and &#x002A;&#x002A;&#x002A;p &#x003c; 0.001, MCAO group vs. Sham group; &#x0023;p &#x003c; 0.05, &#x0023;&#x0023;p &#x003c; 0.01 and &#x0023;&#x0023;&#x0023;p &#x003c; 0.001, dosing group vs. MCAO group.</p>
</caption>
<graphic xlink:href="fphar-16-1636607-g004.tif">
<alt-text content-type="machine-generated">Histological images and bar graphs displaying TNF-&#x00ce;&#x00b1;, IL-1&#x00ce;&#x00b2;, IL-6, and IL-13RA2 positive rates in Sham, MCAO, LM, HM, and HCK groups. Bar graphs indicate significant differences in expression levels among these groups, with symbols denoting statistical significance.</alt-text>
</graphic>
</fig>
<p>The original version of this article has been updated.</p>
</body>
<back>
<sec sec-type="disclaimer" id="s1">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>